{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:51:53Z","timestamp":1788454313856,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Extensive-stage small cell lung cancer (ES-SCLC) in older adults is associated with poor outcomes, and optimal management in this population remains challenging. This study aimed to identify clinical and treatment-related factors associated with survival in patients aged\u2005\u226570 years with ES-SCLC. A retrospective multicenter cohort study included 135 older adults (aged\u2005\u226570 years) diagnosed with ES-SCLC across 3 tertiary centers. All patients received at least 1 cycle of platinum\u2013etoposide\u2013based chemotherapy. Demographic, clinical, and treatment variables \u2013 including metastatic sites, number of chemotherapy cycles, thoracic radiotherapy (TRT), prophylactic cranial irradiation, and palliative radiotherapy to extracranial metastases \u2013 were collected. Survival outcomes were estimated using the Kaplan\u2013Meier method and compared using the log-rank test. Prognostic factors for progression-free survival and overall survival (OS) were evaluated using Cox proportional hazards regression models. The median age was 73.2 years; 88.1% of patients were male. The objective response rate was 69.9%. Median progression-free survival and OS were 7.1 and 8.3 months, respectively (95% CI: 6.09\u20138.17 and 7.67\u20138.93). In multivariate analysis, Eastern Cooperative Oncology Group performance status\u2005\u22652 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;.001), liver metastases (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.006), fewer than 4 chemotherapy cycles (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;.001), absence of prophylactic cranial irradiation (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.028), and lack of palliative radiotherapy to extracranial metastases (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;.001) were independently associated with shorter OS. TRT did not retain statistical significance in multivariate analysis. Only 34.1% of patients received second-line therapy. The 1-year and 2-year OS rates were 33% and 12%, respectively. Fit older adults (Eastern Cooperative Oncology Group performance status 0\u20131) may derive meaningful survival benefit from multimodal treatment strategies. Treatment decisions should be individualized based on functional status rather than chronological age alone. Prospective studies incorporating comprehensive geriatric assessment are warranted.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048711","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:01:36Z","timestamp":1778745696000},"page":"e48711","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0624-1462","authenticated-orcid":false,"given":"Sermin","family":"Dinc Sonusen","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0045-8009","authenticated-orcid":false,"given":"Zehra","family":"Sucuoglu Isleyen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4724-3195","authenticated-orcid":false,"given":"Naime","family":"Afsar Satis","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1466-3887","authenticated-orcid":false,"given":"Mesut","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9542-445X","authenticated-orcid":false,"given":"Bekir","family":"Dogan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8585-9524","authenticated-orcid":false,"given":"Senar","family":"Gunenc","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Yedikule Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4087-4760","authenticated-orcid":false,"given":"Tanju","family":"Berber","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6661-4185","authenticated-orcid":false,"given":"Berna","family":"Akkus Yildirim","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5277-4150","authenticated-orcid":false,"given":"Yaren","family":"Ceran Bas","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-5925","authenticated-orcid":false,"given":"Merve","family":"Ekinci Fidan","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Yedikule Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9373-8693","authenticated-orcid":false,"given":"Resit","family":"Akyel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Yedikule Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5804-6800","authenticated-orcid":false,"given":"Kayhan","family":"Erturk","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-3082","authenticated-orcid":false,"given":"Emir","family":"Celik","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1300-3695","authenticated-orcid":false,"given":"Muhammed Mustafa","family":"Atci","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtho.2022.10.002","article-title":"SCLC: epidemiology, risk factors, genetic susceptibility.","volume":"18","author":"Wang","year":"2023","journal-title":"J Thorac Oncol"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer.","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20260805","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer.","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.20.01055","article-title":"Updated overall survival and PD-L1 subgroup analysis of patients with extensive-stage small-cell lung cancer treated with atezolizumab, carboplatin, and etoposide (IMpower133).","volume":"39","author":"Liu","year":"2021","journal-title":"J Clin Oncol"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1470-2045(20)30539-8","article-title":"Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.","volume":"22","author":"Goldman","year":"2021","journal-title":"Lancet Oncol"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(14)61085-0","article-title":"Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial.","volume":"385","author":"Slotman","year":"2015","journal-title":"Lancet"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa071780","article-title":"Prophylactic cranial irradiation in extensive small-cell lung cancer.","volume":"357","author":"Slotman","year":"2007","journal-title":"N Engl J Med"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(17)30230-9","article-title":"Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jamaoncol.2020.1271","article-title":"Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study.","volume":"6","author":"Rusthoven","year":"2020","journal-title":"JAMA Oncol"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"1132482","DOI":"10.3389\/fimmu.2023.1132482","article-title":"Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era.","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(22)00271-6","article-title":"Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis.","volume":"23","author":"Gaebe","year":"2022","journal-title":"Lancet Oncol"},{"key":"R14-20260805","first-page":"12","article-title":"Cancer statistics, 2024.","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0169-5002(02)00072-7","article-title":"Staging small cell lung cancer: veterans administration lung study group versus international association for the study of lung cancer--what limits limited disease?","volume":"37","author":"Micke","year":"2002","journal-title":"Lung Cancer"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern cooperative oncology group.","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/1759-7714.13977","article-title":"Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: a comprehensive analysis of 358 patients.","volume":"12","author":"Huang","year":"2021","journal-title":"Thorac Cancer"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/JCMA.0000000000000576","article-title":"Treatment patterns and survival in patients with small cell lung cancer in Taiwan.","volume":"84","author":"Chiang","year":"2021","journal-title":"J Chin Med Assoc"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/cncr.31813","article-title":"A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited\u2010stage small cell lung cancer in elderly patients versus younger patients.","volume":"125","author":"Stinchcombe","year":"2018","journal-title":"Cancer"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cllc.2019.05.007","article-title":"Small-cell lung cancer in very elderly (\u2265 80 Years) patients.","volume":"20","author":"Schild","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"e2694","DOI":"10.1136\/spcare-2022-004038","article-title":"Extensive stage small cell lung cancer (ES-SCLC) and palliative care disparities: a national cancer database study.","volume":"14","author":"Khullar","year":"2024","journal-title":"BMJ Support Palliat Care"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/cam4.4938","article-title":"Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancer.","volume":"12","author":"Shiono","year":"2023","journal-title":"Cancer Med"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12885-025-13880-z","article-title":"Real-world data on immunotherapy combined with chemotherapy in elderly patients with extensive-stage small cell lung cancer.","volume":"25","author":"Zhao","year":"2025","journal-title":"BMC Cancer"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"53245","DOI":"10.18632\/oncotarget.10644","article-title":"Prognostic effect of liver metastasis in lung cancer patients with distant metastasis.","volume":"7","author":"Ren","year":"2016","journal-title":"Oncotarget"},{"key":"R27-20260805","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamaoncol.2018.4833","article-title":"Redefining the role of prophylactic cranial irradiation in the modern era of active surveillance in small cell lung cancer.","volume":"5","author":"Eze","year":"2019","journal-title":"JAMA Oncol"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.21037\/jtd.2017.10.10","article-title":"Prophylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again?","volume":"9","author":"Le Pechoux","year":"2017","journal-title":"J Thorac Dis"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.2147\/CMAR.S221225","article-title":"Thoracic radiotherapy benefits elderly extensive-stage small cell lung cancer patients with distant metastasis.","volume":"11","author":"Qi","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jtho.2024.11.011","article-title":"Prophylactic cranial irradiation for patients with SCLC-A new perspective in the immunotherapy era.","volume":"20","author":"Levy","year":"2025","journal-title":"J Thorac Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:01:05Z","timestamp":1785945665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":30,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048711","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2025-09-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}